{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:51:08Z","timestamp":1792788668358,"version":"4.5.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intermittent fasting (IF) and continuous energy restriction (CER) are widely used dietary approaches for metabolic dysfunction\u2013associated steatotic liver disease (MASLD), yet their comparative efficacy remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Web of Science, and Cochrane Central were searched from inception to August 1, 2025, for randomized controlled trials comparing intermittent fasting (IF) with continuous energy restriction (CER) in adults with NAFLD, MAFLD, or MASLD. Risk of bias was assessed using RoB 2, and weighted mean differences were pooled using random-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine trials (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f894) were included, involving time-restricted feeding (TRF), alternate-day fasting (ADF), and 5:2 fasting (whole-day fasting, WDF). Compared with CER, IF was associated with greater reductions in body weight (MD\u202f=\u202f\u22121.29\u202fkg; 95% CI, \u22121.98 to \u22120.61), BMI (MD\u202f=\u202f\u22120.34\u202fkg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ; 95% CI, \u22120.55 to \u22120.13), LDL-C (MD\u202f=\u202f\u22120.08\u202fmmol\/L; 95% CI, \u22120.15 to \u22120.01), and controlled attenuation parameter (CAP) (MD\u202f=\u202f\u221215.13\u202fdB\/m; 95% CI, \u221228.87 to \u22121.39). No significant between-group differences were observed for magnetic resonance imaging\u2013proton density fat fraction (MRI-PDFF), liver stiffness, transaminases, glucose-related indices, total cholesterol, triglycerides, or HDL-C. In subgroup analyses, WDF was associated with a greater reduction in CAP, whereas TRF appeared to be associated with greater reductions in body weight and BMI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with MASLD, intermittent fasting was associated with greater reductions in body weight, BMI, and LDL-C than continuous energy restriction. Although CAP-based analyses suggested a possible advantage of intermittent fasting for hepatic steatosis, this finding was not confirmed by MRI-PDFF and was no longer statistically significant in sensitivity analyses. Further large-scale, long-term randomized trials are needed to confirm these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251149184<\/jats:ext-link>\n                      , Identifier: CRD420251149184.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1833688","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:12:57Z","timestamp":1778674377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Hanlu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Beibei Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianju","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Beibei Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/hep.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/ijms26136518","article-title":"Pharmacological treatment of MASLD: contemporary treatment and future perspectives","volume":"26","author":"Drygalski","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"100256","DOI":"10.1016\/j.jhepr.2021.100256","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet\u2014a randomised controlled trial","volume":"3","author":"Holmer","year":"2021","journal-title":"JHEP Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1517\/13543784.17.3.263","article-title":"The future of obesity: new drugs versus lifestyle interventions","volume":"17","author":"Scheen","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/nu14091781","article-title":"Intermittent fasting versus continuous calorie restriction: which is better for weight loss?","volume":"14","author":"Zhang","year":"2022","journal-title":"Nutrients"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/nutrit\/nuv041","article-title":"Effects of intermittent fasting on body composition and clinical health markers in humans","volume":"73","author":"Tinsley","year":"2015","journal-title":"Nutr Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of intermittent fasting on health, aging, and disease","volume":"381","author":"de Cabo","year":"2019","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/endrev\/bnab027","article-title":"Time-restricted eating for the prevention and management of metabolic diseases","volume":"43","author":"Manoogian","year":"2022","journal-title":"Endocr Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jand.2015.02.018","article-title":"Intermittent fasting and human metabolic health","volume":"115","author":"Patterson","year":"2015","journal-title":"J Acad Nutr Diet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0212","DOI":"10.1097\/HC9.0000000000000212","article-title":"Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"7","author":"Lange","year":"2023","journal-title":"Hepatol Commun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajcnut.2024.10.012","article-title":"Intermittent compared with continuous calorie restriction for treatment of metabolic dysfunction-associated steatotic liver disease: a randomized clinical trial","volume":"121","author":"Sun","year":"2025","journal-title":"Am J Clin Nutr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/meg.0000000000002715","article-title":"Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials","volume":"36","author":"Abuelazm","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jhep.2025.06.005","article-title":"Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease","volume":"83","author":"Oh","year":"2025","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.clinthera.2025.01.007","article-title":"The effect of intermittent fasting diet in comparison with low-calorie diet on inflammation, lipid profile, glycemic index, liver fibrosis in patients with metabolic-associated fatty liver disease (MAFLD): a randomized controlled trial","volume":"47","author":"Karimi","year":"2025","journal-title":"Clin Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/life15050696","article-title":"Effects of intermittent fasting on liver steatosis and fibrosis, serum FGF-21 and autophagy markers in metabolic dysfunction-associated fatty liver disease: a randomized controlled trial","volume":"15","author":"Ozlu Karahan","year":"2025","journal-title":"Life"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e233513","DOI":"10.1001\/jamanetworkopen.2023.3513","article-title":"Effects of time-restricted eating on nonalcoholic fatty liver disease: the TREATY-FLD randomized clinical trial","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12876-019-1132-8","article-title":"Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial","volume":"19","author":"Cai","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cgh.2024.06.051","article-title":"Effects of intermittent calorie restriction in nondiabetic patients with metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Lee","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1439473","DOI":"10.3389\/fnut.2024.1439473","article-title":"Effect of 5: 2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial","volume":"11","author":"Wang","year":"2024","journal-title":"Front Nutr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.3390\/nu15234870","article-title":"Time-restricted fasting improves liver steatosis in non-alcoholic fatty liver disease\u2014a single blinded crossover trial","volume":"15","author":"Feehan","year":"2023","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clnesp.2023.11.009","article-title":"Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis of randomized controlled trials","volume":"59","author":"Saleh","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.12593","article-title":"Short-term intermittent energy restriction interventions for weight management: a systematic review and meta-analysis","volume":"19","author":"Harris","year":"2018","journal-title":"Obes Rev"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1080\/10408398.2020.1757616","article-title":"Impact of intermittent energy restriction on anthropometric outcomes and intermediate disease markers in patients with overweight and obesity: systematic review and meta-analyses","volume":"61","author":"Schwingshackl","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.advnut.2023.10.003","article-title":"Effects of intermittent energy restriction compared with those of continuous energy restriction on body composition and cardiometabolic risk markers\u2014a systematic review and meta-analysis of randomized controlled trials in adults","volume":"15","author":"Schroor","year":"2024","journal-title":"Adv Nutr"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s2468-1253(20)30357-5","article-title":"Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis","volume":"6","author":"Petroff","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/bmjebm-2019-111191","article-title":"The magnitude of small-study effects in the Cochrane database of systematic reviews: an empirical study of nearly 30 000 meta-analyses","volume":"25","author":"Lin","year":"2020","journal-title":"BMJ Evid Based Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/oby.22065","article-title":"Flipping the metabolic switch: understanding and applying the health benefits of fasting","volume":"26","author":"Anton","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41430-020-00821-1","article-title":"Effectiveness of an intermittent fasting diet versus continuous energy restriction on anthropometric measurements, body composition and lipid profile in overweight and obese adults: a meta-analysis","volume":"75","author":"Enr\u00edquez Guerrero","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1090792","DOI":"10.3389\/fnut.2023.1090792","article-title":"Intermittent energy restriction vs. continuous energy restriction on cardiometabolic risk factors in patients with metabolic syndrome: a meta-analysis and systematic review","volume":"10","author":"Xu","year":"2023","journal-title":"Front Nutr"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.3390\/nu13093179","article-title":"Intermittent fasting and the possible benefits in obesity, diabetes, and multiple sclerosis: a systematic review of randomized clinical trials","volume":"13","author":"Morales-Suarez-Varela","year":"2021","journal-title":"Nutrients"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/oby.23568","article-title":"A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss","author":"Elortegui Pascual","year":"","journal-title":"Obesity"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e2139558","DOI":"10.1001\/jamanetworkopen.2021.39558","article-title":"Intermittent fasting and obesity-related health outcomes: an umbrella review of Meta-analyses of randomized clinical trials","volume":"4","author":"Patikorn","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-nutr-071816-064634","article-title":"Metabolic effects of intermittent fasting","volume":"37","author":"Patterson","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12933-024-02263-6","article-title":"Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease","volume":"23","author":"Colantoni","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature10426","article-title":"Dynamics of human adipose lipid turnover in health and metabolic disease","volume":"478","author":"Arner","year":"2011","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/s41591-019-0565-5","article-title":"Adipose lipid turnover and long-term changes in body weight","volume":"25","author":"Arner","year":"2019","journal-title":"Nat Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cmet.2022.01.004","article-title":"A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis","volume":"34","author":"Loft","year":"2022","journal-title":"Cell Metab"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cmet.2016.06.001","article-title":"Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan","volume":"23","author":"Longo","year":"2016","journal-title":"Cell Metab"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"151240","DOI":"10.1016\/j.ejcb.2022.151240","article-title":"Amino acids control blood glucose levels through mTOR signaling","volume":"101","author":"Fan","year":"2022","journal-title":"Eur J Cell Biol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1833688\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:12:58Z","timestamp":1778674378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1833688\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":47,"alternative-id":["10.3389\/fnut.2026.1833688"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1833688","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1833688"}}